TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.

Maha Hussain et al.PubMed ↗Publisher ↗

No numbers read from the abstract.